Canaccord Genuity Maintains Hold on T2 Biosystems, Lowers Price Target to $3
T2 Biosystems, Inc. +7.69% Pre
T2 Biosystems, Inc. TTOO | 1.54 1.54 | +7.69% 0.00% Pre |
Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:
TTOO) with a Hold and lowers the price target from $12 to $3.